1-4 of 4
Ji Xu, MD.
Close
Sort by
Journal Articles

Activating NOTCH1 Mutations Alter T-ALL Chemosensitivity By PREX2-AKT Pathway

Hui Yu, MD, PhD, Yuxin DU, MD, M.S., Ji Xu, MD, PhD, Zhenchang Sun, MD, PhD, Xiaorui Fu, MD, PhD, Ken H. Young, MD, PhD, Mingzhi Zhang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138665
Published: 2020
Journal Articles

Distinct IGHV Repertoire Features In Chinese Chronic Lymphocytic Leukemia Patients

Yi Xia, MD., Wei Xu, MD, PhD, Lei Fan, MD, PhD, Chun Qiao, Li Wang, MD., Ji Xu, MD., Man Wang, MD., Jian-Yong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5279.
https://doi.org/10.1182/blood.V122.21.5279.5279
Published: 2013
Journal Articles

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3034.
https://doi.org/10.1182/blood.V122.21.3034.3034
Published: 2013
Journal Articles

Clinical Study Of Dose-Adjusted EPOCH Regimen For Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis: Preliminary Results Of An Ongoing Phase II Study

Wei Xu, MD, PhD, Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4360.
https://doi.org/10.1182/blood.V122.21.4360.4360
Published: 2013